July 26, 2024 07:00 AM EDT
Peer Review

West­lake's non-opi­oid pain start­up Lati­go gets new leader; Ron Coop­er lands next CEO gig at en­Gene

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Lei Lei Wu

News Reporter

Ni­ma Farzan has joined pain com­pa­ny Lati­go Bio­ther­a­peu­tics af­ter leav­ing Kin­nate Bio­phar­ma, which …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Ky­owa Kirin ac­quires ex-US rights to Ku­ra’s leukemia treat­ment for $330M up­front

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times